FRAN

In 2004 – preclinical trials.
In 2006 - 2007 – clinical trials of the first and second phase.
In 2015 – development of a suppository, a new formula of the drug named FRAN.

The main advantages of the drug «FRAN» are:

• The ability to cure cancer completely in the initial and middle stages of the disease;
• The drug acts on a wide range of cancers, unlike other drugs (which affect only one type of disease)
• The ability to conduct effective therapy at the most severe stages of diseases even in critical condition of the patient;
• The absolute safety of the drug, it does not cause any side effects actions;
• High antimetastatic action: the use of the drug prevents the development of metastases and reduces the size of existing metastases;
• High preventive effect. Preliminary drug administration prevents the development of cancer.
• Availability of raw materials in any volumes in the domestic market: the raw material base does not depend on imports;

What is the difference between FRAN and existing drugs?
The common properties of all chemotherapeutic drugs are high toxicity and a complete lack of selectivity of action, when the drug acts equally on healthy cells of the body and on cancer cells.

The advantage of our project is the uniqueness of the drug. Unlike all other antitumor drugs, FRAN is an absolutely safe drug of natural origin and it does not contain chemical modifiers. This fact determines the unique therapeutic properties of the drug, which will create a very high demand for it in the future.

Research, as well as the opinion of practicing oncologists, suggests that the combination of positive properties makes it unique, without worthy competitors in the antitumor market. This is proved by preclinical trials, clinical trials and more than 500 people who have already been treated with FRAN.

By the sum of the positive qualities combining high antitumor efficacy, absolute selectivity towards tumor cells and complete absence of toxicity, the drug FRAN is unique in comparison with the well-known chemotherapeutic drugs.

The development of the drug FRAN is a revolutionary solution and it opens up a new direction in the science of creating drugs for the safe treatment of cancer and, which is important, it carries out prophylaxis to restore immunity in order to destroy cancer cells at an early stage.

Already, the drug can be ordered by contacting our representatives on our website ufgroup.pro

Yllo blockchain One включает в себя:

Yllo Messenger – мобильное приложение для мгновенного обмена сообщениями, криптоактивами и ведения бизнеса. Децентрализованный мессенджер построенный на кластерной архитектуре. Не имеет центрального сервера. Кроме обычного общения имеет встроенный криптокошелек для хранения и передачи различных криптовалют.

Криптоплатформа – на платформе Yllo можно выпустить любой цифровой актив: с уникальным названием, логотипом и правилами. Эмитент сам задаёт параметры общей эмиссии, инфляции, сжигания, комиссии, распределения, начальной цены и любых других свойств актива.

Брендирование - любой элемент платформы (мессенджер, заметки, кошелёк для ПК) может быть забрендирован под клиента, как персональный инструмент на основе Yllo.

Криптобиржа XLT.One - площадка для обмена классических криптовалют и всех криптоактивов, созданных в Yllo.

Установить приложение yllo для я iOS

Сайт компании